p53 Anti-tumor Research in Bel-7402 by Using Human-derived Vector
DOI:
Author:
Affiliation:

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Science Foundation of China (30500302) and National Basic Research Program of China (2004CB518800).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    In order to study the tumor suppression effect of p53 with CMV enhancer and hTERT promoter mediated by human-derived vector pHrn in liver cancer cell Bel-7402, report plasmid pchEGFP, tumor suppressor plasmids pchp53Arg and pchp53Pro were constructed by inserting expression cassette CMVe+hTERTp+EGFP, CMVe+hTERTp+p53Arg and CMVe+hTERTp+p53Pro into pHrn respectively. 24 h after cell transfection by lipofectamine 2000, GFP expression pattern was analyzed through fluorescence microscope and flow cytometry; RT-PCR and Western blot were taken to study the p53 expression pattern. The cell apoptosis by Hoechst 33258 and Annexin V-FITC/PI staining was also studied. Results show that the expression of GFP and p53 protein in Bel-7402 were detected, but apparent cell apoptosis could not be found. The recombinant p53 mediated by human-derived vector could express in Bel-7402, but no significant tumor suppression effect was detected, which might result from the down regulation effect of the wild type p53 on hTERT promoter.

    Reference
    Related
    Cited by
Get Citation

XUE Zhi-Gang, LI Jian, YIN Biao, ZHANG Ya-Kun, LIU Xiong-Hao, PAN Qian, LONG Zhi-Gao, DAI He-Ping, XIA Kun, WU Ling-Qian, LIANG De-Sheng, XIA Jia-Hui. p53 Anti-tumor Research in Bel-7402 by Using Human-derived Vector[J]. Progress in Biochemistry and Biophysics,2007,34(5):465-470

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 14,2006
  • Revised:December 13,2006
  • Accepted:
  • Online: April 16,2007
  • Published: